Nicotinell Spearmint (Nicotine Polacrilex)

Nicotine Polacrilex is a resin‑bound form of nicotine that releases the active ingredient slowly when placed in the mouth. The released nicotine binds to nicotinic acetylcholine receptors in the brain, partially stimulating them and thereby lessening the intensity of withdrawal symptoms and the urge to smoke.

The appropriate dose of Nicotinell Spearmint is determined by the prescribing clinician based on the individual’s smoking history, level of nicotine dependence, and any co‑existing medical conditions. Patients should follow the healthcare professional’s instructions and not exceed the recommended amount.

Safety data for nicotine Polacrilex in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Nicotinell Spearmint.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

Nicotinell Spearmint delivers nicotine via a buccal resin formulation, offering a slower, more sustained release compared with nicotine gum or lozenges. This can result in smoother symptom control for some users, while other products may provide faster onset. Choice depends on personal preference, tolerability, and clinician recommendation.

Store Nicotinell Spearmint at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, excessive heat, and direct sunlight to maintain stability and potency throughout its shelf life.

The product is placed in the mouth and allowed to dissolve slowly against the buccal mucosa. Users should avoid chewing or swallowing the tablet, and should not eat or drink for a few minutes after placement to ensure optimal nicotine absorption.

Serious risks include allergic reactions such as rash, swelling, or difficulty breathing, and cardiovascular events like palpitations, chest pain, or hypertension. If any of these occur, the product should be discontinued immediately and medical attention sought.

Individuals who are not currently tobacco users, those with known hypersensitivity to nicotine or any excipients, and patients with uncontrolled cardiovascular disease should avoid using Nicotinell Spearmint unless advised otherwise by a qualified healthcare professional.